American Society of Gene & Cell Therapy

⏰ Early registration + ASGCT hotel block access ends tonight at 11:59 pm CT. Secure your registration + hotel accommodations at the lowest rates and explore the latest breakthroughs in targeted in vivo gene editing! Can't make it to #SanDiego on Nov. 20-21? We have you covered with live, virtual registration options and one-year on demand access. https://lnkd.in/eSnMP5t8 #geneediting #ASGCT #invivo #targetedtherapy

🦓 We're so excited to co-host this session with the National Organization for Rare Disorders during the upcoming #NORDSummit! During the session (Oct. 21, 1:40-2:35 p.m. ET) ASGCT President Dr. Terry Flotte will join a panel alongside fellow ASGCT members and leaders: - Dr. P.J. Brooks (National Center for Advancing Translational Sciences (NCATS)) - Dr. Mimi C. Lee (Advanced Research Projects Agency for Health (ARPA-H)) - Dr. Jennifer Adair (UMass Chan Medical School) Attending in person? Visit the ASGCT Outreach team at booth #22 in the exhibit hall to connect and learn more about ongoing CGT #PatientEducation efforts, including a new allied membership category! #raredisease #CGT

✨ THANK YOU to all of the speakers, presenters, sponsors, attendees, and staff who have made Advancing Cell and Gene Therapies for Cancer a success! If you were at the event in Philadelphia, please let us know what you thought! Take our quick survey to provide your feedback: https://bit.ly/476q5VF 💻 If you have registered to watch sessions on demand, you'll receive an email with a direct link next week when they're ready!

🔜 Less than ONE WEEK until our free #MolecularTherapy webinar on advancing #AAV technology! Join us this Wed., Oct. 22, to learn about developments in AAV capsid design and scalable manufacturing. #genetherapy Register HERE: https://lnkd.in/gzdbgpf2

That's a wrap on the first day of our Advancing Cell and Gene Therapies for Cancer conference in Philadelphia! We hope you learned from today's sessions and got to connect with your peers; we'll see you tomorrow morning for Day 2! Let us know what you enjoyed from Day 1 in the comments 👇 👇 #celltherapy #genetherapy #oncology

The Advancing Cell and Gene Therapies for Cancer conference kicks off tomorrow in Philadelphia—the birthplace of gene therapy—and we're looking forward to diving into the latest research on oncolytic viruses, CAR T cells, and innovative combination approaches. Over 1.5 days, leading researchers from institutions like Mayo Clinic, Harvard, Yale, and Baylor will explore: ✨ Next-generation oncolytic virus and cell therapy platforms ✨ Strategies to overcome tumor heterogeneity and delivery challenges ✨ Combinatorial approaches leveraging viral and cellular therapies Can't make it in person? You can register for on-demand access and watch all the sessions at your convenience, with recordings available for up to a year after the event. Whether you're in cancer research, immunotherapy, or gene therapy, this is an opportunity to stay at the forefront of the field and connect with the innovations shaping the future of oncology. Learn more and register: https://bit.ly/4mJEbCH #cancerresearch #genetics #oncology #celltherapy #genetherapy #immunotherapy #immunooncology

💜 Thank you to the Shwachman-Diamond Syndrome Alliance for collaborating with the ASGCT Speaker Bureau to hear insights from Dr. Denise Sabatino (Children's Hospital of Philadelphia) at the SDS POPS Global Patient Advocacy and Partnering Summit. The session focused on shared trends in in vivo approaches, including Baby KJ's story, and what they mean for patient communities.   Shoutout to Dr. Eszter Hars for organizing this with us; we look forward to future collaboration! 

💡 Early Registration Ends NEXT MONDAY for Breakthroughs in Targeted In Vivo Gene Editing   When you book through ASGCT's hotel block, you'll receive the lowest lodging rates, too. Book your lodging and register for this one-of-a-kind conference by October 20!   Conference Overview: 📅 November 20-21, 2025  📍 San Diego + Virtually   Register by October 20 to access early bird pricing; access to ASGCT's hotel block also ends on October 20.   Learn more and register: https://bit.ly/4n7asn9

🌏 Thanks for hosting us at your Congress this week, European Society of Gene and Cell Therapy! #ESGCT2025 Our leaders, ASGCT President Elect Matthew Porteus, MD, PhD, and President Terry Flotte, MD, were excited to gather with other global representatives of the International Coalition of Gene and Cell Therapy Societies on Friday. The Coalition serves as a platform for increased collaboration to create more impactful results, share information about upcoming initiatives and events, and foster the accessibility of #CGTs by improving legislative and regulatory pathways. #celltherapy #genetherapy

🎙️ NEW on the ASGCT Podcast Network! Join Dr. Paloma Giangrande, Editor-in-Chief of #MolecularTherapy Nucleic Acids (#MTNA), as she discusses a recently published MTNA article, Controlling #CRISPR-Cas9 #genomeediting in human cells using a molecular glue degrader, with its authors Dr. Krishanu Saha and Namita Khajanchi, Ph.D. Listen wherever you get podcasts! https://lnkd.in/gpJgpwNN